Stelara 90 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DX25F6XNJ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $16,250
Award facts
- Contract value 100% obligated
- $16,249.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $16,249.95 on July 14, 2025, for the supply of Stelara 90 mg/ml syringes. The contract is firm fixed-price with an ultimate completion date of August 4, 2025, and carries no set-aside designation. The funding originates from the Defense Logistics Agency's Medical Supply Chain, which procures pharmaceutical products to support military and federal healthcare facilities nationwide. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.9 billion vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical items.
Stelara is a biologic medication used primarily to treat autoimmune conditions, and this delivery order represents a routine procurement from DMS Pharmaceutical Group's extensive portfolio of pharmaceutical distributions to Department of Defense healthcare sites. The contractor has consistently demonstrated its capacity to fulfill federal pharmaceutical supply requirements, with a track record of delivery orders covering diverse products including oncology treatments, biologics, vaccines, and specialty medications. This award underscores DMS Pharmaceutical Group's critical role in maintaining the pharmaceutical supply chain for military health facilities and reflects the company's established position as a trusted federal pharmaceutical supplier.
Quick answers
Who was awarded contract SPE2DX25F6XNJ?
SPE2DX25F6XNJ was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on July 14, 2025.
How much is contract SPE2DX25F6XNJ worth?
The government has obligated $16,250 on SPE2DX25F6XNJ.
Is contract SPE2DX25F6XNJ an order under another contract?
Yes. SPE2DX25F6XNJ is a delivery order under SPE2DX15D9168, an indefinite delivery contract.
Was contract SPE2DX25F6XNJ competed?
The extent of competition for SPE2DX25F6XNJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award